Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions
Clinical trial NCT03918551 · COMPLETED
Trial details
- NCT number
- NCT03918551
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-03
- Primary completion
- 2019-06-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.